Trial intelligence / Profile preview

Therapeutic Equivalence of Prasco Estradiol Vaginal Cream vs Estrace in Vulvar and Vaginal Atrophy

NCT03332303Phase 3Completed

Sponsor
Prasco
Start
Oct 2017
Primary completion
Mar 2018
Countries
1
01

Overview

A Phase 3 trial of estradiol topical in vulvovaginal atrophy (VVA), sponsored by Prasco. Started Oct 2017; status: completed.

02

Drugs

estradiol topical
03

Conditions

vulvovaginal atrophy (VVA)

Beyond the preview

Go deeper on NCT03332303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03332303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call